Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher (IT:1TMO)
:1TMO
1TMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range€335.00 - €589.70
Previous CloseN/A
Volume0.00
Average Volume (3M)14.00
Market Cap
$168.83B
Enterprise Value€183.26B
Total Cash (Recent Filing)$6.39B
Total Debt (Recent Filing)$35.23B
Price to Earnings (P/E)28.5
Beta0.52
Next Earnings
Oct 22, 2025EPS Estimate
4.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.57
Shares Outstanding377,612,120
10 Day Avg. Volume7
30 Day Avg. Volume14
Financial Highlights & Ratios
PEG Ratio4.64
Price to Book (P/B)4.01
Price to Sales (P/S)4.63
P/FCF Ratio27.35
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue4.24
Enterprise Value/Gross Profit10.71
Enterprise Value/Ebitda16.08
Forecast
1Y Price Target
$467.70Price Target Upside2.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThermo Fisher reported improved financials for 2Q25, with revenue increasing by 3.0% YoY and adj. EPS declining lightly by 0.2% YoY, both exceeding Bloomberg consensus.
Growth StrategyTMO announced a US$2bn investment plan in the US, including US$1.5bn in Capex, to capture growing opportunities in reshoring manufacturing.
Market PositionThermo's unique cross-sell ability supports above-market organic growth, highlighting its strong positioning in the market.
Bears Say
Market DemandWeak performance in Chemical Analysis and Electron Microscopy due to low demand in China and A&G.
Regulatory And Competitive RisksRisk factors include exposure to biopharma; reliance on government funding and exposure to regulatory markets; considerable global footprint and China exposure; diverse competition across end-markets; acquisition and integration risks; regulatory and safety concerns; and a potential headwind to margins.
Thermo Fisher News
1TMO FAQ
What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest stock price was €335.00 and its highest was €589.70 in the past 12 months.
What is Thermo Fisher’s market cap?
Thermo Fisher’s market cap is $168.83B.
When is Thermo Fisher’s upcoming earnings report date?
Thermo Fisher’s upcoming earnings report date is Oct 22, 2025 which is in 17 days.
How were Thermo Fisher’s earnings last quarter?
Thermo Fisher released its earnings results on Jul 23, 2025. The company reported €4.565 earnings per share for the quarter, beating the consensus estimate of €4.451 by €0.114.
Is Thermo Fisher overvalued?
According to Wall Street analysts Thermo Fisher’s price is currently Undervalued.
Does Thermo Fisher pay dividends?
Thermo Fisher does not currently pay dividends.
What is Thermo Fisher’s EPS estimate?
Thermo Fisher’s EPS estimate is 4.69.
How many shares outstanding does Thermo Fisher have?
Thermo Fisher has 377,612,120 shares outstanding.
What happened to Thermo Fisher’s price movement after its last earnings report?
Thermo Fisher reported an EPS of €4.565 in its last earnings report, beating expectations of €4.451. Following the earnings report the stock price went up 13.114%.
Which hedge fund is a major shareholder of Thermo Fisher?
Currently, no hedge funds are holding shares in IT:1TMO
Thermo Fisher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$467.70 (2.33% Upside)
$467.70 (2.33% Upside)
Blogger Sentiment
Bullish
IT:1TMO Sentiment 83%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $189.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.26%
12-Months-Change
Fundamentals
Return on Equity
13.44%
Trailing 12-Months
Asset Growth
2.78%
Trailing 12-Months
Company Description
Thermo Fisher
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
1TMO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted Thermo Fisher's strong operational performance, driven by growth in the pharma and biotech segments, successful product launches, and strategic partnerships. However, challenges in academia, government, and the China market, along with tariff impacts, presented notable headwinds.View all IT:1TMO earnings summaries1TMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
1TMO Stock 12 Month Forecast
Average Price Target
€467.70
▲(2.33% Upside)
Technical Analysis
Options Prices
Currently, No data available
---